Patents by Inventor Takahiro Nakaminami

Takahiro Nakaminami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11639912
    Abstract: A reagent layer of a sensor contains as a mediator a quinone compound having a hydrophilic functional group, phenanthrenequinone, and/or a phenanthrenequinone derivative. The quinone compound has a lower redox potential than a conventional mediator, so interfering substances have less effect on detection results with this sensor.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: May 2, 2023
    Assignee: PHC HOLDINGS CORPORATION
    Inventors: Yoshifumi Takahara, Takahiro Nakaminami, Shin Ikeda
  • Patent number: 10866205
    Abstract: Voltage is applied across a counter electrode and a working electrode, with which a blood sample is in contact, in such a state that an oxidant in a redox substance is not substantially in contact with a working electrode but is in contact with a counter electrode and a reductant is not substantially in contact with the counter electrode but is in contact with the working electrode, whereby the reductant and the oxidant are respectively oxidized and reduced to measure current produced upon the oxidation and reduction. According to the above constitution, while lowering the voltage applied across the working electrode and the counter electrode, the Hct value of the blood sample can be measured stably with a satisfactory detection sensitivity. This measurement can be carried out with a sensor chip comprising a working electrode (11), a counter electrode (12), and a blood sample holding part (14) having branch parts (18a, 18b).
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: December 15, 2020
    Assignee: PHC Holdings Corporation
    Inventors: Masaki Fujiwara, Shin Ikeda, Takahiro Nakaminami
  • Publication number: 20200348255
    Abstract: A reagent layer of a sensor contains as a mediator a quinone compound having a hydrophilic functional group, phenanthrenequinone, and/or a phenanthrenequinone derivative. The quinone compound has a lower redox potential than a conventional mediator, so interfering substances have less effect on detection results with this sensor.
    Type: Application
    Filed: July 23, 2020
    Publication date: November 5, 2020
    Inventors: Yoshifumi TAKAHARA, Takahiro NAKAMINAMI, Shin IKEDA
  • Patent number: 10761044
    Abstract: A reagent layer of a sensor contains as a mediator a quinone compound having a hydrophilic functional group, phenanthrenequinone, and/or a phenanthrenequinone derivative. The quinone compound has a lower redox potential than a conventional mediator, so interfering substances have less effect on detection results with this sensor.
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: September 1, 2020
    Assignee: PHC HOLDINGS CORPORATION
    Inventors: Yoshifumi Takahara, Takahiro Nakaminami, Shin Ikeda
  • Publication number: 20180217081
    Abstract: Voltage is applied across a counter electrode and a working electrode, with which a blood sample is in contact, in such a state that an oxidant in a redox substance is not substantially in contact with a working electrode but is in contact with a counter electrode and a reductant is not substantially in contact with the counter electrode but is in contact with the working electrode, whereby the reductant and the oxidant are respectively oxidized and reduced to measure current produced upon the oxidation and reduction. According to the above constitution, while lowering the voltage applied across the working electrode and the counter electrode, the Hct value of the blood sample can be measured stably with a satisfactory detection sensitivity. This measurement can be carried out with a sensor chip comprising a working electrode (11), a counter electrode (12), and a blood sample holding part (14) having branch parts (18a, 18b).
    Type: Application
    Filed: March 26, 2018
    Publication date: August 2, 2018
    Inventors: Masaki FUJIWARA, Shin IKEDA, Takahiro NAKAMINAMI
  • Patent number: 9958411
    Abstract: Provided is a sensor chip for electrochemically measuring a concentration of an analyte in a blood sample. In one embodiment of the sensor, the sensor chip includes a substrate, and a preliminary measurement analyzer and a hematocrit value analyzer disposed on the substrate. The preliminary measurement analyzer includes a preliminary working electrode and a preliminary counter electrode. The hematocrit value analyzer includes a working electrode and a counter electrode. An oxidant of a redox substance is disposed on the preliminary measurement analyzer and the counter electrode. A reductant of a redox substance is disposed on the working electrode.
    Type: Grant
    Filed: December 9, 2015
    Date of Patent: May 1, 2018
    Assignee: Panasonic Healthcare Holdings Co., Ltd.
    Inventors: Masaki Fujiwara, Shin Ikeda, Takahiro Nakaminami
  • Publication number: 20160091453
    Abstract: Provided is a sensor chip for electrochemically measuring a concentration of an analyte in a blood sample. In one embodiment of the sensor, the sensor chip includes a substrate, and a preliminary measurement analyzer and a hematocrit value analyzer disposed on the substrate. The preliminary measurement analyzer includes a preliminary working electrode and a preliminary counter electrode. The hematocrit value analyzer includes a working electrode and a counter electrode. An oxidant of a redox substance is disposed on the preliminary measurement analyzer and the counter electrode. A reductant of a redox substance is disposed on the working electrode.
    Type: Application
    Filed: December 9, 2015
    Publication date: March 31, 2016
    Inventors: Masaki FUJIWARA, Shin IKEDA, Takahiro NAKAMINAMI
  • Publication number: 20160061764
    Abstract: A reagent layer of a sensor contains as a mediator a quinone compound having a hydrophilic functional group, phenanthrenequinone, and/or a phenanthrenequinone derivative. The quinone compound has a lower redox potential than a conventional mediator, so interfering substances have less effect on detection results with this sensor.
    Type: Application
    Filed: November 10, 2015
    Publication date: March 3, 2016
    Inventors: Yoshifumi TAKAHARA, Takahiro NAKAMINAMI, Shin IKEDA
  • Patent number: 9244037
    Abstract: Provided is a sensor chip for electrochemically measuring a concentration of an analyte in a blood sample. In one embodiment of the sensor, the sensor chip includes a substrate, and a preliminary measurement analyzer and a hematocrit value analyzer disposed on the substrate. The preliminary measurement analyzer includes a preliminary working electrode and a preliminary counter electrode. The hematocrit value analyzer includes a working electrode and a counter electrode. An oxidant of a redox substance is disposed on the preliminary measurement analyzer and the counter electrode. A reductant of a redox substance is disposed on the working electrode.
    Type: Grant
    Filed: March 18, 2013
    Date of Patent: January 26, 2016
    Assignee: Panasonic Healthcare Holdings Co., Ltd.
    Inventors: Masaki Fujiwara, Shin Ikeda, Takahiro Nakaminami
  • Patent number: 9212380
    Abstract: A reagent layer of a sensor contains as a mediator a quinone compound having a hydrophilic functional group, phenanthrenequinone, and/or a phenanthrenequinone derivative. The quinone compound has a lower redox potential than a conventional mediator, so interfering substances have less effect on detection results with this sensor.
    Type: Grant
    Filed: August 30, 2010
    Date of Patent: December 15, 2015
    Assignee: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
    Inventors: Yoshifumi Takahara, Takahiro Nakaminami, Shin Ikeda
  • Patent number: 8691072
    Abstract: Voltage is applied across a counter electrode and a working electrode, with which a blood sample is in contact, in such a state that an oxidant in a redox substance is not substantially in contact with a working electrode but is in contact with a counter electrode and a reductant is not substantially in contact with the counter electrode but is in contact with the working electrode, whereby the reductant and the oxidant are respectively oxidized and reduced to measure current produced upon the oxidation and reduction. According to the above constitution, while lowering the voltage applied across the working electrode and the counter electrode, the Hct value of the blood sample can be measured stably with a satisfactory detection sensitivity. This measurement can be carried out with a sensor chip comprising a working electrode (11), a counter electrode (12), and a blood sample holding part (14) having branch parts (18a, 18b).
    Type: Grant
    Filed: October 17, 2007
    Date of Patent: April 8, 2014
    Assignee: Panasonic Corporation
    Inventors: Masaki Fujiwara, Shin Ikeda, Takahiro Nakaminami
  • Patent number: 8673127
    Abstract: In a biosensor for measuring a specific substance in a liquid sample, one or a combination of sugar alcohol, metallic salt, organic acid or organic acid salt which has at least one carboxyl group in a molecule, and organic acid or organic acid salt which has at least one carboxyl group and one amino group in a molecule, is included in a reagent layer provided on electrodes, thereby providing a highly-accurate biosensor which is excellent in stability and has high response (sensitivity, linearity) of the sensor to the substrate concentration.
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: March 18, 2014
    Assignee: Panasonic Corporation
    Inventors: Shoji Miyazaki, Hiroyuki Tokunaga, Masaki Fujiwara, Takahiro Nakaminami, Junko Nakayama, Eriko Yamanishi
  • Patent number: 8399259
    Abstract: The measuring device of the invention includes: a first container and a second container for holding a sample; and an optical measurement part for carrying out an optical measurement. The first container has a first sample supply inlet for supplying a sample containing an analyte to the first container and at least one electrode. The second container has a second sample supply inlet for supplying the sample to the second container and a reagent holding part for holding a reagent for the optical measurement.
    Type: Grant
    Filed: April 28, 2010
    Date of Patent: March 19, 2013
    Assignee: Panasonic Corporation
    Inventors: Atsushi Fukunaga, Takahiro Nakaminami, Akihito Kamei
  • Publication number: 20120152763
    Abstract: A reagent layer (4) of a sensor (1) contains as a mediator a quinone compound having a hydrophilic functional group, phenanthrenequinone, and/or a phenanthrenequinone derivative. The quinone compound has a lower redox potential than a conventional mediator, so interfering substances have less effect on detection results with this sensor 1.
    Type: Application
    Filed: August 30, 2010
    Publication date: June 21, 2012
    Inventors: Yoshifumi Takahara, Takahiro Nakaminami, Shin Ikeda
  • Publication number: 20110301499
    Abstract: A body fluid sampling device (100) includes: a connecting portion (105) to which a body fluid container is connected; a suctioning portion (117) which suctions a gas in the body fluid container connected to the connecting portion, to introduce a body fluid into the body fluid container; a suctioning passage (105a) which causes an inside of the suctioning portion and an inside of the body fluid container connected to the connecting portion, to be communicated with each other; a first electrode (112) which is disposed to extend across the suctioning passage and has gas permeability; a second electrode (113) which is disposed to extend across the suctioning passage and be opposed to the first electrode, and has gas permeability; and a detector which detects an electric signal generated between the first electrode and the second electrode.
    Type: Application
    Filed: August 9, 2011
    Publication date: December 8, 2011
    Applicant: Panasonic Corporation
    Inventor: Takahiro NAKAMINAMI
  • Publication number: 20110180404
    Abstract: In a biosensor for measuring a specific substance in a liquid sample, one or a combination of sugar alcohol, metallic salt, organic acid or organic acid salt which has at least one carboxyl group in a molecule, and organic acid or organic acid salt which has at least one carboxyl group and one amino group in a molecule, is included in a reagent layer provided on electrodes, thereby providing a highly-accurate biosensor which is excellent in stability and has high response (sensitivity, linearity) of the sensor to the substrate concentration.
    Type: Application
    Filed: December 21, 2010
    Publication date: July 28, 2011
    Inventors: Shoji Miyazaki, Hiroyuki Tokunaga, Masaki Fujiwara, Takahiro Nakaminami, Junko Nakayama, Eriko Yamanishi
  • Publication number: 20110151572
    Abstract: A method for measuring the concentration of creatinine includes the steps of: (A) mixing a sample containing creatinine with a creatinine quantitative reagent including 1-methoxy-5-methylphenazinium in the absence of picric acid and any enzyme responsive to creatinine, to cause the creatinine to reduce the 1-methoxy-5-methylphenazinium; (B) electrochemically or optically measuring the amount of the 1-methoxy-5-methylphenazinium reduced in the step (A); and (C) determining the concentration of the creatinine contained in the sample from the amount of the reduced 1-methoxy-5-methylphenazinium measured in the step (B).
    Type: Application
    Filed: December 16, 2010
    Publication date: June 23, 2011
    Applicant: PANASONIC CORPORATION
    Inventors: Takahiro NAKAMINAMI, Hiroaki Tachibana, Masato Suzuki
  • Patent number: 7960132
    Abstract: A measuring device (100a) includes a base body (101) constituting: a sample holding portion (102) configured to hold a test sample containing urea and a material to be detected; and a sample supply port (103) through which the test sample is supplied to the sample holding portion (102). The base body includes an optical measuring portion and a reagent holding portion (111) which are configured to carry out an optical measurement of the test sample held by the sample holding portion (102). The reagent holding portion holds an antibody to the material to be detected and urease which causes hydrolysis of the urea. With this, the present invention provides a measuring device, a measuring apparatus, and a measuring method, each having a simple configuration and capable of reducing measurement errors caused by the urea contained in the test sample and accurately measuring the material to be detected.
    Type: Grant
    Filed: February 20, 2009
    Date of Patent: June 14, 2011
    Assignee: Panasonic Corporation
    Inventors: Takahiro Nakaminami, Jin Muraoka
  • Patent number: 7879617
    Abstract: A method for measuring the concentration of creatinine includes the steps of: (A) mixing a sample containing creatinine with a creatinine quantitative reagent including 1-methoxy-5-methylphenazinium in the absence of picric acid and any enzyme responsive to creatinine, to cause the creatinine to reduce the 1-methoxy-5-methylphenazinium; (B) electrochemically or optically measuring the amount of the 1-methoxy-5-methylphenazinium reduced in the step (A); and (C) determining the concentration of the creatinine contained in the sample from the amount of the reduced 1-methoxy-5-methylphenazinium measured in the step (B).
    Type: Grant
    Filed: January 6, 2010
    Date of Patent: February 1, 2011
    Assignee: Panasonic Corporation
    Inventors: Takahiro Nakaminami, Hiroaki Tachibana, Masato Suzuki
  • Publication number: 20110014712
    Abstract: A method for measuring a concentration of creatinine includes the steps of: (A) mixing a sample containing creatinine with a creatinine quantitative reagent containing a metal complex of at least one of hexacyanoferrate and hexacyanoruthenate in the absence of picric acid and any enzyme responsive to creatinine, to cause the creatinine to reduce the metal complex; (B) electrochemically or optically measuring the amount of the metal complex reduced in the step (A); and (C) determining the concentration of the creatinine contained in the sample from the amount of the reduced metal complex measured in the step (B).
    Type: Application
    Filed: September 28, 2010
    Publication date: January 20, 2011
    Applicant: PANASONIC CORPORATION
    Inventors: Takahiro NAKAMINAMI, Kouji Kashiwada, Atsushi Fukunaga